Patient gets relief after living 30 years with incorrect asthma diagnosis – Medical Xpress

Patient gets relief after living 30 years with incorrect asthma diagnosis
Medical Xpress
Patients are often misdiagnosed with asthma and Chronic Obstructive Pulmonary Disease (COPD), and they present with a chronic barking cough, severe shortness of breath and chest pain. Haskin was referred to UC Health—"I love UC, and have had great …

and more »

View full post on asthma – Google News

Propeller Health gets FDA clearance for updated asthma device – Madison.com


mobihealthnews

Propeller Health gets FDA clearance for updated asthma device
Madison.com
Propeller Health has approval from the U.S. Food and Drug Administration to sell an updated version of its Propeller device, designed to help monitor and control asthma and COPD (chronic obstructive pulmonary disease). Propeller Health's device
Propeller Health Receives New FDA Clearance for Next Generation Propeller PR Newswire (press release)
Propeller gets FDA clearance for new inhaler, COPD platformmobihealthnews

all 4 news articles »

View full post on asthma – Google News

Teva’s DuoResp Spiromax gets positive CHMP opinion to treat asthma and COPD – Pharmaceutical Business Review

Teva's DuoResp Spiromax gets positive CHMP opinion to treat asthma and COPD
Pharmaceutical Business Review
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid for the treatment of underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting 
Teva's Symbicort generic backed for EU approvalPMLiVE
10 new medicines recommended for approval in EuropePharmaTimes

all 3 news articles »

View full post on asthma – Google News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And … – RTT News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And
RTT News
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid to treat the underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting beta2 
EU Agency backs respiratory drugs for approvalReuters UK
EMA Backs Generic Versions of AstraZeneca's SymbicortBloomberg

all 7 news articles »

View full post on asthma – Google News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And … – NASDAQ

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And
NASDAQ
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid to treat the underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting beta2 
UPDATE 1-EU Agency backs respiratory drugs for approvalReuters
EMA Backs Generic Versions of AstraZeneca's SymbicortBloomberg

all 7 news articles »

View full post on asthma – Google News

Yourwellness Magazine Gets Behind Asthma Sufferer’s Charity Climb – PR Web (press release)

Yourwellness Magazine Gets Behind Asthma Sufferer's Charity Climb
PR Web (press release)
On the 15th of September, a lifelong asthma sufferer will climb Mount Snowdon to raise money for an international aid charity. Gary Evans (35) hopes to raise at least £500 for CARE International. Father-of-three Evans told the Spalding Guardian, “I was 

View full post on asthma – Google News